2013 -Welcome to the Nolta Lab at the University Of California, Davis: Health Sciences Campus in Sacramento
CIRM announces funding for disease team therapy research grants, 3 of the four top scores in the state belonging to UC Davis!
CIRM press release:
Listen to KQED Forum Interview with Jan Nolta and Alan Trounson - July 27, 2012 (60 minutes)
Our laboratory works in translational biology at the GLP, or “good laboratory practice” level, required to take stem cell therapies, gene therapy and tissue repair studies from the bench to the bedside.
Dr. Nolta is Director of the UC Davis Stem Cell Program and Scientific Director of the GMP facility and assists other Principal Investigators with the rules and regulations involved with obtaining approvals from the Recombinant advisory committee (RAC) and the FDA for cellular therapies. She works closely with Dr. Gerhard Bauer, the Director of the Good Manufacturing Practice Facility in the UC Davis Institute for Regenerative Cures.
Basic/translational work in our lab centers around developing stem cell therapies for peripheral vascular disease and other ischemic disorders, and using stem cells to treat neurodegenerative disorders, primarily focusing on Huntington's Disease.